COGT - Cogent Biosciences files for mixed shelf offering; size not disclosed

• Cogent Biosciences ( NASDAQ: COGT ) has filed for a mixed shelf offering of an unspecified amount.
• The filing does not necessarily indicate that a sale has begun, or will occur in the future.
• The company intends to use the proceeds for development and commercial preparation activities related to bezuclastinib, as well as for working capital and general corporate purposes.
• The offering can include common stock, preferred stock, debt securities, warrants, and units.
• Read why Seeking Alpha contributor Zach Bristow considers Cogent ( COGT ) a hold.

For further details see: